A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Mandler, 1993, Devic's neuromyelitis optica: a clinicopathological study of 8 patients, Ann Neurol, 34, 162, 10.1002/ana.410340211

O'Riordan, 1996, Clinical, CSF, and MRI findings in Devic's neuromyelitis optica, J Neurol Neurosurg Psychiatry, 60, 382, 10.1136/jnnp.60.4.382

Wingerchuk, 1999, The clinical course of neuromyelitis optica (Devic's syndrome), Neurology, 53, 1107, 10.1212/WNL.53.5.1107

Cree, 2002, Neuromyelitis optica, Semin Neurol, 22, 105, 10.1055/s-2002-36534

Misu, 2002, Pure optic-spinal form of multiple sclerosis in Japan, Brain, 125, 2460, 10.1093/brain/awf260

Kira, 2003, Multiple sclerosis in the Japanese population, Lancet Neurol, 2, 117, 10.1016/S1474-4422(03)00308-9

Lee, 1991, Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT, Neurology, 41, 657, 10.1212/WNL.41.5.657

Mandler, 1998, Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine, Neurology, 51, 1219, 10.1212/WNL.51.4.1219

Goodin, 2002, Disease-modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines, Neurology, 58, 169, 10.1212/WNL.58.2.169

Keegan, 2002, Plasma exchange for severe attacks of CNS demyelination: predictors of response, Neurology, 58, 143, 10.1212/WNL.58.1.143

Weinshenker, 2003, Neuromyelitis optica: what it is and what it might be, Lancet, 361, 889, 10.1016/S0140-6736(03)12784-5

Yu, 2001, CRMP 5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity, Ann Neurol, 49, 146, 10.1002/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E

Poser, 1983, New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann Neurol, 13, 227, 10.1002/ana.410130302

Moore, 2002, Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy, Nature, 418, 422, 10.1038/nature00838

Lucchinetti, 2002, A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica, Brain, 125, 1450, 10.1093/brain/awf151

de Seze, 2003, Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis, Mult Scler, 9, 521, 10.1191/1352458503ms947oa

Hoch, 2001, Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies, Nat Med, 7, 365, 10.1038/85520

Lennon, 2003, Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease., J Clin Invest, 111, 907, 10.1172/JCI17429